Browse
Submit Data
Databases
API
Help

Dataset Information

0 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

Functional rare and low frequency variants in BLK and BANK contribute to human lupus pathogenesis

ABSTRACT: Functional rare and low frequency variants in BLK and BANK contribute to human lupus pathogenesis

PROVIDER: PRJNA522453 | ENA |

REPOSITORIES: ENA

ACCESS DATA

Json Xml

Similar Datasets

Functional rare and low frequency variants in BLK and BANK contribute to human lupus pathogenesis

Project description:Systemic lupus erythematosus (SLE) is the prototypic systemic autoimmune disease. It is thought that many common variant gene loci of weak effect act additively to predispose to common autoimmune diseases, while the contribution of rare variants remains unclear. Here we describe that rare coding variants in lupus-risk genes are present in most SLE patients and healthy controls. We demonstrate the functional consequences of rare and low frequency missense variants in the interacting proteins BLK and BANK, which are present alone, or in combination, in a substantial proportion of lupus patients. The rare variant found in patients, but not those found exclusively in controls, impair suppression of IRF and type-I IFN in human B cell lines and increase pathogenic lymphocytes in lupus-prone mice. Thus, rare gene variants are common in SLE and likely contribute to genetic risk.

2019-05-01 | GSE126307 | GEO

SNParray data for banking lines in Korea National Stem Cell Bank

Project description:Copy number variantions (CNVs) were calculated using SNP array data for banking lines in Korea National Stem Cell Bank.

2021-01-05 | GSE163134 | GEO

Rare coding variants in lupus risk genes

Project description:Systemic lupus erythematosus (SLE) is the prototypic systemic autoimmune disease. It is thought that many common variant gene loci of weak effect act additively to predispose to common autoimmune diseases, while the contribution of rare variants remains unclear. Here we describe that rare coding variants in lupus-risk genes are present in most SLE patients and healthy controls. We demonstrate the functional consequences of rare and low frequency missense variants in the interacting proteins BLK and BANK1, which are present alone, or in combination, in a substantial proportion of lupus patients. The rare variants found in patients, but not those found exclusively in controls, impair suppression of IRF5 and type-I IFN in human B cell lines and increase pathogenic lymphocytes in lupus-prone mice. Thus, rare gene variants are common in SLE and likely contribute to genetic risk.

| EGAS00001003548 | EGA

FDA-CDC Antimicrobial Resistance Bank

Project description:FDA-CDC Antimicrobial Resistance Bank

| PRJNA294416 | ENA

Common, low-frequency, rare, and ultra-rare coding variants contribute to COVID-19 severity.

Project description: Not available

| S-EPMC8661833 | biostudies-literature

Establishment of a Tumor Bank for Tissue Samples

Project description:Establishment of a tumor bank, consisting of tissue samples of tumor patients (benign and malign tumors) and healthy people as controls. The tissue samples will be collected systematically together with the corresponding clinical data. The biological samples, the clinical date together with prospective experimental date constitute the entity of the tissue tumor bank. This tumor bank for tissue samples, together with our tumorbank for blood samples (NCT01763125) combined constitute the entity "Tumorbank".

| 2139890 | ecrin-mdr-crc

Glomerular Transcriptome from European Renal cDNA Bank subjects and living donors

Project description:summary : Glomerular Transcriptome from European Renal cDNA Bank subjects and living donors. Samples included in this analysis have been previously analyzed using older CDF definitions and are included under previous GEO submissions - GSE47183 (chronic kidney disease samples), and GSE32591 (IgA nephropathy samples).

2018-01-24 | GSE104948 | GEO

Establishment of a Tumor Bank for Blood Samples

Project description:Establishment of a tumor bank, consisting of blood samples of tumor patients and healthy people as controls. The blood samples will be collected systematically together with the corresponding clinical data. The biological samples, the clinical date together with prospective experimental date constitute the entity of the tumor bank.

| 2137891 | ecrin-mdr-crc

FDA/CDC Antimicrobial Resistant Isolate Bank

Project description:FDA/CDC Isolate Bank Genome Sequencing

| PRJNA316321 | ENA

Universal stool bank donors

Project description:16S rRNA sequencing of samples from universal stool bank donors

| PRJEB41316 | ENA